FDA Adverse Event Malfunction Summary report: N

INRATIO

MDR report key: 872823 · Received June 26, 2007

Report

Report Number
2954730-2007-00285
Event Type
Malfunction
Date Received
June 26, 2007
Date of Event
June 11, 2007
Report Date
June 20, 2007
Manufacturer
HEMOSENSE, INC.
Product Code
JPA
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
UNKNOWN

Narratives

Additional Manufacturer Narrative · 1

DISCREPANT RESULTS (ACCURACY) COMPARISON OF INRATIO TEST WITH LAB RESULTS PROVIDED BY END-USER AT TIME COMPLAINT WAS FILED: DATE: 2007; INRATIO: 2.0; LAB: 2.2; MEAN:2.1; CONFIDENCE LIMITS: 1.4 -3.1. DATE: SAME DAY; INRATIO: 3.1; LAB: 3.1; MEAN:3.1; CONFIDENCE LIMITS: 1.9 -4.6. PER INTERNAL PROCEDURE, THE MEAN OF THE INRATIO METER AND COMPARATIVE SYSTEM INR WERE CALCULATED. BOTH INRATIO AND LAB VALUES ARE WITHIN THE CONFIDENCE LIMITS FOR INR TESTING. THE RESULTS ARE NOT CONSIDERED DISCREPANT WITHIN THE CONTEXT OF THE DOCUMENTED VARIABILITY FOR INR TESTING. THEREFORE, FURTHER TESTING IS NOT REQUIRED AT THIS TIME. DUE TO THE FACT THAT THE CUSTOMER HAD BLOOD IN HIS URINE/STOOL AND HE WENT TO THE ER, AND WAS TESTED FOR PT/INR AND INR WAS VERY HIGH (NO ACTUAL NO OBTAINED) PER DEE, THIS QUALIFIES THIS CASE AS AN ADVERSE EVENT. ALSO PER TS UPDATE ON THE SAME DAY, PT WAS GIVEN 10MG OF VIT K, DC COUMADIN AND IV WAS GIVEN. PRODUCT WILL BE TESTED WHEN RETURNED.

Description of Event or Problem · 1

CALLER ALLEGES INACCURACY WITH INRATIO. RESULTS AS FOLLOWS: DATE: 2007; INRATIO: 2.0; LAB: 2.2. DATE: SAME DAY. INRATIO: 3.1; LAB: 3.1. DUE TO THE FACT THAT THE CUSTOMER HAD BLOOD IN HIS URINE/STOOL AND HE WENT TO THE ER, AND WAS TESTED FOR PT/INR AND INR WAS VERY HIGH (NO ACTUAL NO OBTAINED). THIS QUALIFIES THIS CASE AS AN ADVERSE EVENT. ALSO PER TS UPDATE ON THE NEXT DAY, PT WAS GIVEN 10 MG OF VIT K, DC COUMADIN AND IV WAS GIVEN.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 INRATIO PROTHROMBIN TIME TEST JPA HEMOSENSE, INC. 070195

Patients

Seq Age Sex Outcome Treatment
1 YR Hospitalization| R